Search Within

Heiko Schoder

  1. "Center for Molecular Imaging and Biotechnology (CMIB)"
Formats
  1. Journal Article (29)
  2. Meeting Abstract (19)
  3. Book Section (3)
  4. Review (3)
  5. Research Letter (2)
  6. Editorial (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (57)
  2. GSK Faculty (57)
  3. Molecular Imaging and Therapy Service (57)
  4. Radiology, Department of (57)
  5. Department of Medicine (39)
  6. Molecular Pharmacology and Chemistry Program Faculty (31)

More Groups

People
  1. Hedvig Hricak (17)
  2. Santosha Vardhana (17)
  3. Alison Moskowitz (16)
  4. Anita Kumar (16)
  5. Jason Lewis (16)
  6. Andrew Zelenetz (15)

More People

Years
  1. 2025 (3)
  2. 2024 (8)
  3. 2023 (8)
  4. 2022 (3)
  5. 2021 (6)
  6. 2020 (6)

More Years

Publications
  1. Blood (10)
  2. Journal of Clinical Oncology (9)
  3. Journal of Nuclear Medicine (6)
  4. Clinical Cancer Research (3)
  5. European Journal of Nuclear Medicine and Molecular Imaging (3)
  6. Hematological Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. American Society of Clinical Oncology (9)
  3. Society of Nuclear Medicine (6)
  4. Elsevier Inc. (5)
  5. American Association for Cancer Research (4)
  6. Nature Publishing Group (3)

More Publishers

Results (57)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
    Journal Article

    Raj, S. S.; Fei, T.; Fried, S.; Ip, A.; Fein, J. A.; Leslie, L. A.; Alarcon Tomas, A.; Leithner, D.; Peled, J. U.; Corona, M.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • IL13Rα2-targeting antibodies for immuno-PET in solid malignancies
    Journal Article

    Gajecki, L.; Lebedeva, I. V.; Liao, Y. R.; Ambriz, D.; Carter, L. M.; Kumpf, M.; Lovibond, S.; Hachey, J. S.; Graham, M. S.; Postow, M.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Anti-GPA33 pretargeted radioimmunotherapy (PRIT) of colorectal cancer (CRC) using a self-assembling and dis-assembling (SADA) bispecific antibody to deliver 177Lu-bivalent benzyl-DOTA
    Meeting Abstract

    Le Roux, A.; Fung, E.; Xu, H.; Vargas, D. B.; Rinne, S. S.; Guo, H. F.; Leung, K.; Feng, Y.; Cheung, I.; Ouerfelli, O.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save